Kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon in an infant girl

Louise Helligsø1, Torben Stamm Mikkelsen2, Anne-Mette Hvas3

  • 1Present address: Department of Ophtalmology Aarhus University Hospital Aarhus Denmark.

Clinical Case Reports
|September 18, 2023
PubMed

Insights

This case study details the successful treatment of a rare infant mediastinal Kaposiform hemangioendothelioma (KHE). The treatment was complicated by Kasabach-Merritt Phenomenon (KMP), infections, and pericardial effusion.

Area of Science:

  • Pediatric Oncology
  • Vascular Biology
  • Hematology

Background:

  • Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor.
  • Tufted angiomas share similar characteristics with KHE.
  • Kasabach-Merritt Phenomenon (KMP) is a rare complication associated with KHE and tufted angiomas.

Observation:

  • A female infant presented with a mediastinal KHE.
  • The infant experienced complications including KMP, severe thrombocytopenia, hypofibrinogenemia, elevated D-dimer, life-threatening infections, and pericardial effusion.

Findings:

  • Successful treatment of mediastinal KHE in an infant was achieved.
  • Treatment involved a combination of prednisolone, vincristine, and sirolimus.
  • This multimodal approach managed KHE, KMP, infections, and pericardial effusion.

Implications:

  • This case highlights a successful, albeit complex, treatment strategy for a rare pediatric vascular tumor.
  • The findings suggest that a combination of prednisolone, vincristine, and sirolimus can be effective in managing complicated KHE.
  • Further research is needed due to the lack of standardized treatment protocols for KHE.